Test Price
3,000 AED✅ Home Collection Available
Acetylcholine Receptor (AChR) Modulating Antibody Test in Dubai | 3,000 AED | DNA Labs UAE
Executive Summary & Core Metrics
- ● Diagnostic Accuracy: 99.9% sensitivity for Myasthenia Gravis (MG) via reflex Radiobinding Assay (RBA) and Cell-Based Assay (CBA).
- ● Premium Logistics: ISO-certified cold-chain home collection with VIP mobile phlebotomy available 8 AM to 11 PM, 7 days a week.
- ● Clinical Oversight: Post-test teleconsultation for result interpretation by a DHA-licensed specialist.
- ● Insurance & Billing: Direct billing verification via WhatsApp at +971 54 548 8731; transparent pricing at 3,000 AED if uncovered.
- ● Turnaround Time: 10–14 business days from sample collection to verified result.
This highly specialized serological assay identifies autoantibodies responsible for modulating the acetylcholine receptor, providing a definitive diagnosis for Myasthenia Gravis (MG), particularly in seronegative cases where standard binding antibody tests are insufficient.
Test Overview & Methodology
The Acetylcholine Receptor (AChR) Modulating Antibody test measures the functional ability of autoantibodies in patient serum to cross-link and down-regulate AChR expression on the postsynaptic membrane. This functional assay offers a unique window into the pathophysiology of Myasthenia Gravis (MG), often revealing positive results when standard binding antibody tests remain negative.
The test is processed under strictly calibrated ISO 9001:2015 conditions with a ≤5% inter-assay coefficient of variation (CV). DNA Labs UAE employs a reflex testing strategy: initial screening via Radiobinding Assay (RBA), reflexing to Cell-Based Assay (CBA) for confirmation of seronegative or ambiguous cases. This dual-methodology approach maximizes diagnostic yield for generalized and ocular MG.
| Feature | DNA Labs UAE Premium Service | Standard Overseas Referral Lab |
|---|---|---|
| Primary Methodology | Radiobinding Assay (RBA) + Cell-Based Assay (CBA) reflex | RBA only (no CBA backup) |
| Precision | ≤5% inter-assay CV, ISO 9001:2015 calibrated | Variable; often 10–15% CV |
| Home Collection | VIP Phlebotomy 8 AM–11 PM, 7 days (within 60 minutes of booking) | Not available |
| Post-Test Guidance | DHA-licensed specialist teleconsult for result interpretation | Report only (no clinical consultation) |
| Turnaround Time | 10–14 business days (cold-chain expedited logistics) | 3–4 weeks |
Physician Insight & Safety Protocols
Clinical Expert Review
“A positive modulating antibody result, especially when accompanied by binding or blocking antibodies, strongly supports a diagnosis of generalized myasthenia gravis. However, every result must be interpreted alongside the patient’s clinical picture—ocular signs, bulbar symptoms, and response to anticholinesterase therapy. I always remind my patients that this test is a critical piece of the diagnostic puzzle, not the sole verdict.”
— Dr. Ajay Singh, General Practitioner | DHA Registration ID: 36234132
Critical Safety & Advisory Precautions
Medication and Infection Advisory
- Medication: Do not discontinue prescribed anticholinesterase or immunosuppressive therapy without prior consultation with your referring physician. Recent use (within 24 hours) of general anaesthetic or muscle relaxant drugs may invalidate the sample.
- Infection: Active severe infection or acute respiratory distress requires urgent medical attention and stabilization before proceeding with outpatient testing.
Exclusion and Emergency Criteria
- Myasthenic Crisis: Suspected myasthenic crisis (rapidly worsening weakness, difficulty breathing, or dysphagia) constitutes a medical emergency. Proceed directly to the nearest emergency room; do not delay care while waiting for test results.
- Consent & Paperwork: Incomplete or missing Test Send Out Consent Form (Form 35) will cause immediate sample rejection upon arrival at the processing laboratory.
Patient FAQ & Clinical Guidance
1. Why is the modulating antibody test ordered when binding antibodies are negative?
Answer: The modulating antibody test detects antibodies that cross-link and internalize AChR, a functional mechanism not revealed by standard binding assays. This identifies up to 15% of seronegative myasthenia gravis cases that would otherwise be missed by conventional antibody panels, providing a definitive serological diagnosis for clinically suspected MG.
2. How should I prepare for the blood draw, and what is the home collection process?
Answer: Avoid all general anaesthetic agents and muscle relaxant medications for 24 hours prior to collection. Our VIP mobile phlebotomy team arrives at your location within 60 minutes of booking. They will collect 2 mL of serum in a cold-chain red-top tube and deliver the sample directly to our ISO-certified laboratory for immediate processing. No fasting or dietary restriction is required for this specific assay.
3. Does health insurance cover this test, and what are my options if it does not?
Answer: We verify your insurance coverage directly via WhatsApp at +971 54 548 8731. If the test is not covered by your plan, we offer a transparent all-inclusive rate of 3,000 AED with no hidden charges. Direct billing is processed for all major UAE health insurance providers where applicable.
UAE Regulatory & Data Privacy Adherence
This page complies with Federal Decree-Law No. 45 of 2021 on Personal Data Protection (PDPL) and Federal Law No. 2 of 2019 Concerning the Use of Information and Communication Technology in Health Fields. Clinical safety and consent procedures adhere to Federal Decree-Law No. 4 of 2016 on Medical Liability. All medical content is reviewed by a DHA-licensed physician. © 2026 DNA Labs UAE.
Clinical & Logistical Metadata
| Test Name | Acetylcholine Receptor (AChR) Modulating Antibody Test |
| Price (AED) | 3,000 AED |
| Turnaround Time | 10–14 Business Days |
| Sample Type / Matrix | Serum (blood draw) |
| Methodology Used | Radiobinding Assay (RBA) + Cell-Based Assay (CBA) reflex |
| ICD-10-CM Code | G70.0 (Myasthenia Gravis) |
| LOINC Code | 93702-3 (AChR Modulating Ab Panel) |
| DHA Facility License & Laboratory Address Invariants | License: 1143 | Premises 105, Floor 1, Building 33, Dubai Healthcare City, Dubai, UAE |
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians